Compare Ginkgo Bioworks Holdings Inc (DNA) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs JetBlue Airways Corporation — how do they compare? Ginkgo Bioworks Holdings Inc trades at $9.06 (market cap $590.53M), while JetBlue Airways Corporation trades at $5.34 (market cap $1.99B). The key difference: JetBlue Airways Corporation is far larger — about 3.4× Ginkgo Bioworks Holdings Inc's market cap, and JetBlue Airways Corporation is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | JBLU | |
|---|---|---|
Market Cap | $590.53M | $1.99B |
Sector | Health | Industrials |
52-Week High | $16.14 | $6.46 |
52-Week Low | $5.48 | $4.03 |
Enterprise Value | $627.78M | $9.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DNA trades at $9.05, down 0.44% on the day, reflecting ongoing investor caution. The technical outlook is bearish, while fundamentals show significant losses with a net income margin of -201.05% and negative cash flows. Recent earnings have been mixed, missing estimates in two of the last three quarters. Analyst sentiment is divided, with a slight lean toward buy ratings amid high volatility and operational challenges.
The outlook remains challenging due to persistent losses and cash burn, though analyst coverage suggests potential long-term value. Key risks include execution missteps and intense competition in biotechnology. Investment appeal hinges on future profitability improvements and successful business model execution.
JetBlue (JBLU) trades at $5.60, down 2.78% on the day, with a neutral technical signal and mixed fundamental picture. The airline reported negative net income margins of -7.78% and has missed earnings expectations in recent quarters, though it beat in Q3 2025. Recent news highlights expansion at Fort Lauderdale airport and sector-wide pressure from fuel costs. Analyst consensus is mixed with 61% hold ratings and a $5.12 price target slightly below current levels.
The outlook remains challenging with persistent losses and high debt levels, though strategic expansions and potential fuel cost relief offer some upside. Key risks include competitive pressures, volatile fuel prices, and execution of turnaround efforts. The stock presents a speculative opportunity for investors betting on operational improvements amid sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
